Propanc Biopharma
(NASDAQ) PPCB
Propanc Biopharma Financials at a Glance
Market Cap
$1.88M
Revenue (TTM)
$29.90K
Net Income (TTM)
$66.07M
EPS (TTM)
$-13.54
P/E Ratio
-0.01
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.12
Volume
3,900
Open
$0.12
Price
$0.12
Volume
3,900
Open
$0.12
Previous Close
$0.12
Daily Range
$0.12 - $0.12
52-Week Range
$0.11 - $11.00
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.12
Volume
3,900
Open
$0.12
Previous Close
$0.12
Daily Range
$0.12 - $0.12
52-Week Range
$0.11 - $11.00
PPCB News
PPCB: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Propanc Biopharma
Industry
Biotechnology
Sector
Health CareEmployees
2
CEO
James Andrew Nathanielsz
Website
www.propanc.comHeadquarters
Camberwell, VIC 3124, AU
PPCB Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
-2177%
Net Income Margin
-2209%
Return on Equity
-2100%
Return on Capital
-6%
Return on Assets
-4%
Earnings Yield
-100.00%
Dividend Yield
0.00%
Payout Ratio
-1.41%
Stock Overview
Market Cap
$1.88M
Shares Outstanding
15.86M
Volume
3.90K
Short Interest
0.00%
Avg. Volume
1.83M
Financials (TTM)
Gross Profit
$0.00
Operating Income
$57.28M
EBITDA
$58.34M
Operating Cash Flow
$405.17K
Capital Expenditure
$0.00
Free Cash Flow
$405.17K
Cash & ST Invst.
$12.09K
Total Debt
$1.73M
Propanc Biopharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$6.03K
-39.2%
Gross Margin
0.00%
N/A
Market Cap
$1.88M
N/A
Market Cap/Employee
$1.88M
N/A
Employees
1
N/A
Net Income
$3.09M
-618.6%
EBITDA
$3.65M
-1090.8%
Quarterly Fundamentals
Net Cash
$1.12M
+6.0%
Accounts Receivable
$16.99K
+761.3%
Inventory
$0.00
N/A
Long Term Debt
$1.07M
+1200.3%
Short Term Debt
$613.97K
-45.5%
Return on Assets
-4.37%
N/A
Return on Invested Capital
-5.67%
N/A
Free Cash Flow
$999.14K
-15832.7%
Operating Cash Flow
$999.14K
-15832.7%